Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway
- 1 March 2016
- journal article
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 53, 84-95
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG030399, AG037814)
This publication has 100 references indexed in Scilit:
- Hyperinsulinemia in newly diagnosed patients with multiple sclerosisMetabolic Brain Disease, 2015
- Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspringBrain, Behavior, and Immunity, 2015
- Altered cognitive-emotional behavior in early experimental autoimmune encephalitis – Cytokine and hormonal correlatesBrain, Behavior, and Immunity, 2013
- Dysregulation of immune homeostasis in autoimmune diseasesNature Medicine, 2012
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2010
- Astrocyte-Restricted Ablation of Interleukin-17-Induced Act1-Mediated Signaling Ameliorates Autoimmune EncephalomyelitisImmunity, 2010
- Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunityProceedings of the National Academy of Sciences, 2009
- Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's diseaseNeurobiology of Disease, 2006
- IL-17 Plays an Important Role in the Development of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006